Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Russell Owens

Urology Camp Hill, PA Medical Doctor

NPI 1154319135 CMS profile 6624

100 Corporate Center Dr Ste 100, Camp Hill, PA 17011

Open in the dashboard

General payments

$8,150

98 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Russell Owens of Camp Hill, PA is reported in the CMS Open Payments database as having received $8,150 across 98 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,557 6
2024 General $3,421 21
2022 General $132 3
2021 General $1,099 16
2020 General $329 9
2019 General $1,613 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Russell Owens
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Russell Owens were reported at $1,557. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Russell Owens Urology median Middle half National median
2019 $1,613 $480 $147–$1,201 $163
2020 $329 $246 $87–$645 $114
2021 $1,099 $358 $111–$1,000 $132
2022 $132 $476 $143–$1,263 $149
2023 $0 $560 $168–$1,461 $160
2024 $3,421 $563 $170–$1,464 $164
2025 $1,557 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $3,922 18 payments
  2. PROCEPT BioRobotics Corporation $1,752 10 payments
  3. NeoTract Inc. $1,409 10 payments
  4. Astellas Pharma US Inc $493 20 payments
  5. AbbVie, Inc. $142 7 payments
  6. Pfizer Inc. $127 22 payments
  7. Teleflex LLC $117 2 payments
  8. Allergan Inc. $50 1 payment
  9. Janssen Biotech, Inc. $27 2 payments
  10. Palette Life Sciences, Inc. $26 1 payment
  11. Other $86 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $4,335 15 payments
  2. Food and Beverage $2,866 79 payments
  3. Education $940 3 payments
  4. Gift $9 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $3,172 17 payments
  2. UROLIFT $1,409 10 payments
  3. AQUABEAM SYSTEM $1,125 7 payments
  4. DA VINCI SP $750 1 payment
  5. AQUABEAM ROBOTIC SYSTEM $627 3 payments
  6. XTANDI $262 25 payments
  7. MYRBETRIQ $147 10 payments
  8. UroLift System $117 2 payments
  9. LUPRON DEPOT $64 3 payments
  10. BOTOX $50 1 payment
  11. Other $258 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

705

Median for Urology: 1,053

Drug cost

$50,752

Median for Urology: $101,464

Branded share of claims

24%

Median for Urology: 27.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Myrbetriq Mirabegron Brand 31 $32,891
Tamsulosin Hcl Generic 326 $9,036
Dutasteride Generic 94 $4,795
Alfuzosin Hcl Er Alfuzosin Hcl Brand 42 $1,715
Oxybutynin Chloride Er Oxybutynin Chloride Brand 39 $874
Solifenacin Succinate Generic 14 $719
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 57 $231
Ciprofloxacin Hcl Generic 60 $184
Finasteride Generic 15 $159
Oxybutynin Chloride Generic 16 $88

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 10,221 Part D prescribers listed as Urology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 66 billing codes

Paid by Medicare

$140,480

Of which drugs: $16,501

Medicare patients

754

Average age 75

Services billed

7,698

73 women, 681 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 45%
Cancer 42%
Ischemic heart disease 29%
Chronic kidney disease 28%
Diabetes 26%
Atrial fibrillation 18%
Heart failure 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, docetaxel, 1 mg J9171 Office 31 3,990 $2,546
Injection, gemcitabine hydrochloride, 200 mg J9201 Office 25 350 $872

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $40
$40 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

98 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record